January 26, 2022
2 min read
Save

Weight loss may not improve fertility in women with obesity, yet it confers other benefits

Weight loss may not improve fertility in women with obesity, yet it confers other benefits

Among women with obesity and unexplained infertility, weight loss before infertility treatment did not increase the likelihood of having a healthy live birth, according to findings published in PLoS Medicine.

January 26, 2022
1 min watch
Save

VIDEO: George Martin, MD, gives cutaneous oncology updates

VIDEO: George Martin, MD, gives cutaneous oncology updates

WAILEA, Hawaii — In this video perspective from Maui Derm for Dermatologists, George Martin, MD, the meeting’s program director, gives an update on cutaneous oncology treatment options that were discussed during the meeting’s first day.

January 26, 2022
3 min read
Save

Ripretinib fails to improve PFS in advanced gastrointestinal stromal tumor

Ripretinib did not extend PFS compared with sunitinib for patients with advanced gastrointestinal stromal tumor who previously received imatinib, according to randomized phase 3 study results presented during the ASCO Plenary Series.

January 26, 2022
2 min read
Save

Nutrient-dense foods may help reduce cholesterol among statin-intolerant patients

Nutrient-dense foods may help reduce cholesterol among statin-intolerant patients

Substituting a small portion of food with nutrient-dense foods may effectively lower cholesterol among patients with hyperlipidemia without the use of drugs, according to findings published in the Journal of Nutrition.

January 26, 2022
2 min read
Save

FDA approves Kimmtrak for unresectable or metastatic uveal melanoma

FDA approves Kimmtrak for unresectable or metastatic uveal melanoma

The FDA approved tebentafusp-tebn for the treatment of adults with HLA-A*02:01-positive unresectable or metastatic uveal melanoma.

January 26, 2022
2 min read
Save

Mineralocorticoid receptor antagonists may stave off renal replacement therapy in CKD

Mineralocorticoid receptor antagonists may stave off renal replacement therapy in CKD

In a real-world outpatient population, mineralocorticoid receptor antagonist use in patients with chronic kidney disease was associated with lower rates of renal replacement therapy initiation compared with nonuse, researchers reported.

January 26, 2022
1 min read
Save

ACC 2022 late-breaking trials to address cardiomyopathy, acute MI, flu vaccine and more

ACC 2022 late-breaking trials to address cardiomyopathy, acute MI, flu vaccine and more

The virtual 2022 American College of Cardiology Scientific Session will be held from April 2 to 4, and will feature 25 late-breaking clinical trials, 10 featured clinical research presentations and numerous abstract presentations.

January 26, 2022
6 min read
Save

Q&A: Study to assess single oral immunotherapy’s ability to treat multiple food allergens

Q&A: Study to assess single oral immunotherapy’s ability to treat multiple food allergens

Oral immunotherapy has shown promise in inducing remission of specific food allergies, with one FDA-approved option available for peanut allergy, but these patients often shoulder the burden of multiple food allergies.

January 26, 2022
2 min read
Save

Removing race-specific coefficient in eGFR equation impacts CKD trial inclusion

Removing race-specific coefficient in eGFR equation impacts CKD trial inclusion

Removing the race-specific coefficient from the equation that determines eGFR results in a “small but potentially important” effect on the inclusion of patients in [chronic kidney disease] trials, according to published data.

January 26, 2022
2 min read
Save

Data show ‘vulnerable window’ for recurrent ACS

Data show ‘vulnerable window’ for recurrent ACS

The initial 90‐day window after ACS represents a vulnerable period for recurrent events, possibly attributable to atherothrombosis mechanisms not currently addressed with optimal therapy, researchers reported.

Ophthalmology
Neuromyelitis Optica Spectrum Disorder: Reducing Relapse Through Early Intervention
1.25
CME
1.25
CME WITH ABO CONTINUING CERTIFICATION
75
MINS
$0
FEE
Hematology/Oncology
Video
Save

A Glimpse Into the Future of Myeloma Patient Management

Support for this activity has been provided through educational grants from AbbVie, Amgen, Bristol Myers Squibb, Karyopharm Therapeutics, Oncopeptides, and Sanofi Genzyme.

The joint sponsors also wish to thank CURE and Targeted Oncology for their support

A Glimpse Into the Future of Myeloma Patient Management
2.50
CME
150
MINS
$0
FEE
Hematology/Oncology
Ace the Case
Save

Ace the Case: A 22-Year-Old Man With Hemophilia A and Knee Pain/Swelling

There is no commercial support for this activity.

0.25
CME
0.25
CME WITH ABIM MOC
15
MINS
$0
FEE
Gastroenterology
Ace the Case
Save

Ace the Case: A 28-Year-Old Man With a 6-Month History of a Burning Sensation in His Chest

There is no commercial support for this activity.

Ace the Case: A 28-Year-Old Man With a 6-Month History of a Burning Sensation in His Chest
0.25
CME
0.25
CME with ABIM MOC
15
MINS
$0
FEE
Neurology
Ace the Case
Save

Ace the Case: A 38-Year-Old Man With Ischemic Stroke

There is no commercial support for this activity.

Image of Brain
0.25
CME
0.25
CME with ABIM MOC
15
MINS
$0
FEE
Cardiology
Ace the Case
Save

Ace the Case: A 64-Year-Old Man With a 10-Year History of Type 2 Diabetes With Increasing Weight Gain and Uncontrolled Diabetes

There is no commercial support for this activity.

0.25
CME
0.25
CME with ABIM MOC
15
MINS
$0
FEE
Pulmonology
Ace the Case
Save

Ace the Case: A 34-Year-Old Woman With Dyspnea on Exertion

There is no commercial support for this activity.

Ace the Case: A 34-Year-Old Woman With Dyspnea on Exertion
0.25
CME
0.25
CME with ABIM MOC
15
MINS
$0
FEE
Ophthalmology
Podcast
Save

Cerebrospinal Fluid Pressure and Glaucoma

This activity is supported by educational grants from Aerie Pharmaceuticals, Inc.; Allergan, Inc.; Bausch + Lomb; and Carl Zeiss Meditec, Inc.

Image of Human Brain
0.50
CME
0.50
CME WITH ABO CONTINUING CERTIFICATION
30
MINS
$0
FEE